A recent study from Johns Hopkins University suggests that a popular cholesterol-lowering drug, rosuvastatin, may increase the risk of kidney problems, especially at higher doses. This finding could ...

The other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the ...